Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating obese polycystic ovary syndrome

A technology of polycystic ovary and composition, which is applied in the field of pharmaceutical composition for the treatment of obese polycystic ovary syndrome, and can solve problems such as side effects and poor therapeutic effect

Inactive Publication Date: 2021-06-08
THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above drugs are ineffective and have certain side effects, and patients with polycystic ovary syndrome usually need a relatively long-term medication treatment process, so it is particularly urgent to seek safe and effective drugs for the treatment of polycystic ovary syndrome

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Recipe: 6 grams of ginger pinellia, 30 grams of fairy spleen, 10 grams of atractylodes, 20 grams of poria cocos, 12 grams of tangerine peel, 30 grams of Dipsacus, 10 grams of Cyperus cyperi, 20 grams of salvia miltiorrhiza, 10 grams of Achyranthes bidentata, 10 grams of plantago seed, cinnamon 6 grams, Zhi Licorice 6 grams.

[0033] Preparation:

[0034] Mix ginger pinellia, xianlingpi, atractylodes atractylodes, Poria cocos, tangerine peel, Dipsacus cyperi, Cyperus cyperi, Salvia miltiorrhiza, Achyranthes bidentata, plantain seed, cinnamon and roasted licorice, add water to decoct twice, filter (the first time add 7-10 Double the amount of water, decoct for 30 minutes; add 5-8 times the amount of water for the second time, decoct for 20 minutes), combine the filtrates, and get ready.

[0035] The decocted filtrate is taken orally, twice a day in the morning and evening, and three menstrual cycles are a course of treatment.

Embodiment 2

[0037]Recipe: 4 grams of ginger pinellia, 35 grams of fairy spleen, 8 grams of atractylodes, 24 grams of Poria, 10 grams of tangerine peel, 35 grams of Dipsacus, 8 grams of Rhizoma Cyperus, 24 grams of Salvia, 8 grams of Achyranthes bidentata, 12 grams of plantago, cinnamon 4 grams, Zhi Licorice 8 grams.

[0038] The preparation method of the pharmaceutical composition is the same as in Example 1, and then prepared into capsules in a conventional manner.

Embodiment 3

[0040] Recipe: 8 grams of ginger pinellia, 25 grams of fairy spleen, 12 grams of atractylodes, 16 grams of poria cocos, 14 grams of dried tangerine peel, 25 grams of Dipsacus, 12 grams of Cyperus cyperi, 16 grams of salvia miltiorrhiza, 12 grams of Achyranthes bidentata, 8 grams of plantago seed, cinnamon 8 grams, Zhi Licorice 4 grams.

[0041] The preparation method of the pharmaceutical composition is the same as in Example 1, and then prepared into pills in a conventional manner.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating obese polycystic ovary syndrome. The raw materials are composed of 4-8 parts of ginger pinellia, 25-35 parts of fairy spleen, 8-12 parts of atractylodes rhizome, 16-24 parts of poria cocos, 10-14 parts of tangerine peel, 25-35 parts of Dipsacus, 8-12 parts of Cyperus cyperi, 16-24 parts of Salvia miltiorrhiza, 8-12 parts of Achyranthes knuckles, 8-12 parts of plantain seed, 4-8 parts of cinnamon, 4 parts of roasted licorice ‑8 servings. The medicinal materials selected for the pharmaceutical composition of the present invention are compatible, the prescriptions are refined, and the functions complement each other. The purpose is to promote dampness and eliminate phlegm, and it integrates expectorant, warming kidney, promoting qi, invigorating the spleen, promoting blood circulation, and tonifying. Significant; in terms of medicinal properties, they are compatible with each other, with less toxic and side effects.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating obese polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common gynecological endocrine metabolic disease characterized by long-term anovulation and androgen excess. It is a syndrome with multiple pathogenesis and diverse clinical manifestations. The prevalence rate is as high as 5-12% in women of childbearing age, and its main clinical manifestations are menstrual disorders, infertility, obesity, hirsutism, acne, etc., which not only increase the risk of gestational diabetes and pregnancy-induced hypertension, but also increase the risk of endometrial hyperplasia. Cancer, diabetes, atherosclerosis, coronary heart disease and other long-term metabolic diseases have a serious impact on women's quality of life. Long-term anovulation brings harm to women's physical and mental ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8905A61P15/08
CPCA61K36/076A61K36/185A61K36/21A61K36/284A61K36/296A61K36/484A61K36/537A61K36/54A61K36/68A61K36/752A61K36/8888A61K36/8905A61K2236/331A61K2236/39A61K2300/00
Inventor 王克华刘卉张鑫睿尚国梁葛彦
Owner THE AFFILIATED HOSPITAL OF SHANDONG UNIV OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com